Durable remission of pemphigus with a fixed-dose rituximab protocol K Heelan, F Al-Mohammedi, MJ Smith, S Knowles, P Lansang, S Walsh, ... JAMA dermatology 150 (7), 703-708, 2014 | 102 | 2014 |
Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant K Heelan, JF Ryan, NH Shear, CA Egan Journal of Dermatological Case Reports 7 (4), 113, 2013 | 69 | 2013 |
Factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas: development and external validation of a predictive nomogram A Maurichi, R Miceli, H Eriksson, J Newton-Bishop, J Nsengimana, ... Journal of Clinical Oncology 38 (14), 1591, 2020 | 62 | 2020 |
Pemphigus and associated comorbidities: a cross‐sectional study K Heelan, AL Mahar, S Walsh, NH Shear Clinical and experimental dermatology 40 (6), 593-599, 2015 | 51 | 2015 |
Cutaneous drug reactions in children: an update K Heelan, NH Shear Pediatric Drugs 15, 493-503, 2013 | 43 | 2013 |
Pemphigus herpetiformis: a case series and review of the literature PM Laws, K Heelan, F Al‐Mohammedi, S Walsh, NH Shear International journal of dermatology 54 (9), 1014-1022, 2015 | 42 | 2015 |
Neonatal lupus syndrome associated with ribonucleoprotein antibodies K Heelan, R Watson, SM Collins Pediatric Dermatology 30 (4), 416-423, 2013 | 41 | 2013 |
Treatment of mucous membrane pemphigoid with rituximab K Heelan, S Walsh, NH Shear Journal of the American Academy of Dermatology 69 (2), 310-311, 2013 | 37 | 2013 |
Cost and resource use of pemphigus and pemphigoid disorders pre-and post-rituximab K Heelan, S Hassan, G Bannon, S Knowles, S Walsh, NH Shear, ... Journal of Cutaneous Medicine and Surgery 19 (3), 274-282, 2015 | 33 | 2015 |
Intractable erosive lichen planus treated successfully with rituximab K Heelan, MA McAleer, L Roche, C McCreary, M Murphy British Journal of Dermatology 172 (2), 538-540, 2015 | 31 | 2015 |
Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat SL Chan, RE Watchorn, E Panagou, E Panou, ELH Ong, K Heelan, ... Australasian Journal of Dermatology 60 (3), e201-e207, 2019 | 27 | 2019 |
Fumaric acid esters as a suitable first‐line treatment for severe psoriasis: an Irish experience K Heelan, T Markham Clinical and experimental dermatology 37 (7), 793-795, 2012 | 20 | 2012 |
Use of rituximab in pemphigus patients with chronic viral hepatitis: Report of three cases AJ Kanwar, K Vinay, K Heelan, S Walsh, NH Shear, RK Dhiman Indian Journal of Dermatology, Venereology and Leprology 80, 422, 2014 | 18 | 2014 |
Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses K Heelan, SL Hitzig, S Knowles, AM Drucker, N Mittmann, S Walsh, ... Journal of Cutaneous Medicine and Surgery 19 (6), 546-554, 2015 | 17 | 2015 |
Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study A Kawsar, C Edwards, P Patel, RM Heywood, A Gupta, J Mann, ... British Journal of Dermatology 187 (6), 981-987, 2022 | 15 | 2022 |
Cutaneous reactions to drugs K Heelan, C Sibbald, NH Shear Fitzpatrick’s Dermatology in General Medicine 9th ed. 9th ed. McGraw-Hill …, 2019 | 14 | 2019 |
Pseudoxanthoma elasticum‐like papillary dermal elastolysis: a case report and review of literature E Panagou, M Ratynska, K Heelan International Journal of Dermatology 58 (1), 93-97, 2019 | 14 | 2019 |
Localized genital bullous pemphigoid SJ Mounsey, K Heelan, S Hughes, H Fawcett, CB Bunker Clinical and Experimental Dermatology 43 (7), 810-812, 2018 | 11 | 2018 |
Case of fatal immune-related skin toxicity from sequential use of osimertinib after pembrolizumab: Lessons for drug sequencing in never-smoking non-small-cell lung cancer W Cui, C Cotter, KB Sreter, K Heelan, D Creamer, TN Basu, J Handy, ... JCO oncology practice 16 (12), 842-844, 2020 | 10 | 2020 |
Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience S Chawla, A Hill, L Fearfield, S Johnston, M Parton, K Heelan Breast Cancer Research and Treatment 188, 535-545, 2021 | 8 | 2021 |